Direxion Daily S&P Biotech Bear 3X ETF
LABD
4 hedge funds and large institutions have $4.67M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.
135% more capital invested
Capital invested by funds: $1.99M → $4.67M (+$2.69M)
90% more call options, than puts
Call options by funds: $20.1M | Put options by funds: $10.6M
0% more ownership
Funds ownership: 0% → 0.01% (+0%)
33% less funds holding
Funds holding: 6 → 4 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTUS
Flow Traders U.S.
New York
|
+$3.07M |
| 2 |
CG
Cutler Group
San Francisco,
California
|
+$384K |
| 3 |
Jane Street
New York
|
+$128K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$128K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$572K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$184K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$143K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$90K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$39K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FTUS
1
Flow Traders U.S.
New York
| $2.5M | +$3.07M | +24 | New |
|
|
2
Jane Street
New York
| $1.74M | +$128K | +1 | +7% |
|
|
CG
3
Cutler Group
San Francisco,
California
| $303K | +$384K | +3 | New |
|
|
4
Simplex Trading
Chicago,
Illinois
| $93K | +$128K | +1 | New |
|
5
Morgan Stanley
New York
| $30K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| – | -$572K | -9 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$184K | -3 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | -$143K | -2 | Closed |
|
|
9
Creative Planning
Overland Park,
Kansas
| – | -$90K | -1 | Closed |
|
|
10
UBS Group
Zurich,
Switzerland
| – | -$39K | -1 | Closed |
|
LABD Hedge Fund Activity: Q1 2016 in Review
4 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q1 2016, worth a combined $4.67M — up 135% from $1.99M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LABD and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Flow Traders U.S., opening a new position worth an estimated $3.07M. The largest seller was Virtu Financial, exiting entirely with an estimated $572K sold.
- 4 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q1 2016, down from 6 in Q4 2015.
- Funds reported $4.67M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q1 2016, up 135% quarter-over-quarter.
- 3 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q1 2016 and 5 closed out, a net change of -2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q1 2016 was Flow Traders U.S., an estimated $3.07M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q1 2016 was Virtu Financial, an estimated $572K sold.
Based on aggregated 13F filings for Q1 2016.